Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Gold Kropn Bio-technology is a leading global manufacturer specializing in chitin and its derivatives, including chitosan and glucosamine. Founded in 1994 and headquartered in Yuhuan, China, the company operates large-scale production facilities that adhere to international quality standards such as GMP, ISO, and HALAL. Their product portfolio serves diverse sectors, including pharmaceuticals, nutraceuticals, food processing, and agriculture. Gold Kropn is particularly recognized for its high-purity pharmaceutical-grade glucosamine, which is widely used in the treatment of osteoarthritis and joint health supplements. Additionally, the company produces various grades of chitosan utilized in advanced wound care, drug delivery systems, and water treatment applications. With a strong focus on R&D and quality control, Gold Kropn has established itself as a key supplier to major international markets across North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Gold Kropn Bio-technology.